Martin Shkreli: Big Pharma's Blind Spot, Betting Against Quantum & What Prison Taught Him

Martin Shkreli joins the All-In hosts to deliver his unfiltered take on three topics. He explains why he sees quantum computing as a one-trick business and is betting against it. He also argues that big pharma routinely underprices critical drugs—a blind spot he exploited as a hedge fund trader before moving into the industry. Finally, he reflects on AI in drug discovery, who actually captures the value, and gets personal about the gifted-kid trap and what prison taught him.